SCHEMBL5403699

SCHEMBL5403699

CC(C)(C)c1ccc2c(c1)C(C)(C)CC2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.53
ALDH1A1 P00352 3/20 0.43
NPC1 O15118 1/20 0.43
PLA2G1B P04054 1/20 0.43
NFKB1 P19838 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
TDP2 O95551 1/20 0.34
KDM4E B2RXH2 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14457104 0.86 ALDH1A1 (0.43) PGRALDH1A1NPC1PLA2G1BNFKB1
SCHEMBL4426124 0.78 PGR (0.62) PGRALDH1A1TDP2MEN1KMT2A
SCHEMBL3368868 0.77 PGR (0.69) PGRALDH1A1KDM4ECA1CA9
SCHEMBL13113557 0.75 PGR (0.55) PGRALDH1A1KDM4EHPGDTDP1
SCHEMBL388355 0.75 PGR (0.55) PGRALDH1A1KDM4ECA1CA9
SCHEMBL20951359 0.75 PGR (0.55) PGRALDH1A1NPC1PLA2G1BRAB9A
SCHEMBL3361527 0.75 PGR (0.55) PGRALDH1A1TDP2KDM4ECA1
SCHEMBL192717 0.75 PGR (0.69) PGRTDP2MEN1KMT2A
SCHEMBL14827606 0.73 HDAC3 (0.44) PGRALDH1A1NPC1PLA2G1BNFKB1
SCHEMBL4420953 0.72 PGR (0.77) PGRALDH1A1NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-7208142-B2 Indanylidene compounds SYMRISE GMBH & CO. KG (DE) 2007-04-24 US disclosed
EP-1466892-A1 Novel indanylidene compounds Symrise GmbH & Co. KG (DE) 2004-10-13 EP disclosed
EP-1341752-B1 NOVEL INDANYLIDENE COMPOUNDS SYMRISE GMBH & CO KG (DE) 2004-08-04 EP disclosed
CN-1473146-A Novel indanylidene compounds ������������� 2004-02-04 CN disclosed
EP-1341752-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2003-09-10 EP disclosed
US-20020143203-A1 Novel indanylidene compounds SYMRISE GMBH & CO. KG (DE) 2002-10-03 US disclosed
WO-2002038537-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185057-A1 Novel Indanone Compounds CUTA, NISCH, TYR PGR 3055/4885ALDH1A1 434/4885NPC1 2490/4885
US-20020143203-A1 Novel indanylidene compounds CUTA, NISCH, ERCC4 PGR 3741/4885ALDH1A1 373/4885NPC1 1907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.